Industry Conferences & Events

IHI's Program on Leading Patient Safety

September 11 - 17, 2010 Cambridge, MA
Attend IHI's Patient Safety Program where you'll develop detailed, customized patient safety strategies and implementation plans.

Drug Safety Surveillance and Epidemiology

September 20 - 22, 2010 Horsham, PA
Participate in discussion on ways to apply the role of epidemiology and risk management, from both industry and FDA perspectives.

The Safety Continuum in the Medical Product Life Cycle

September 22 - 24, 2010 Baltimore, MD
Assessing and Managing Risk from Preclinical Testing through Clinical Trials to Post-Approval & Marketing in the US & Abroad

13th Registries and Post-Approval Studies Congress

September 28 - 30, 2010 Princeton , NJ
CBI has successfully built and maintained a franchise in the Post-Approval space with unmatched research and industry admired speakers and continues that tradition for 2010!

Global Approach to the Risk Management of Medicines

September 30 -
October 1, 2010
Washington, DC
Join Authorities, Global Regulators, Industry Representatives, and Marketing Application Holders for an Interactive Discussion of RMPs.
This workshop aims to provide a neutral platform for regulators and industry to jointly review experience from pharmacovigilance audits and inspections across national boundaries
Interact with Senior FDA Members to Explore Emerging Issues in Cardiovascular Safety and Diabetic Drug Development.

DIA Maternal and Pediatric Drug Safety Symposium

October 13 - 14, 2010 Bethesda, MD
Join Leaders from Industry, Academia, CDC, FDA, EMA, and WHO to Discuss Emerging Topics in Maternal and Pediatric Drug Safety.

Safety Assessment of Serious Adverse Events in CNS

October 21 - 22, 2010 Vienna , VA
CBI is proud to expand on its drug safety series with the inaugural Safety Assessment of Serious Adverse Events in CNS.

Pharmacovigilance Asia 2010

October 26 - 27, 2010 Singapore
A one-of-its kind conference exploring effective risk management to improve drug safety and protect consumers’ well-being
Join Industry and International Regulatory Leaders to Address Multiregional Clinical Trial Opportunities and Risks from a Global Perspective

7th DIA Japan Annual Meeting

October 28 - 29, 2010 Tokyo, Japan
This conference aims to contribute to the further advancement of international clinical development by deepening the mutual understanding among those working in the pharmaceutical industry, academia and regulatory authorities.
The program will highlight information on improving efficiency in the running of clinical trials; discussion of streamlining federal and provincial regulatory and formulary approvals; and advice on strategies to overcome obstacles.

CHI's Post-Approval Drug Safety Strategies

November 8 - 9, 2010 Philadelphia, PA
Cambridge Healthtech Institute’s and the BioPharma Strategy Series’ fifth annual executive forum Post-Approval Drug Safety Strategies

CHI's Mitigating Safety Risks in Early Clinical Development

November 8 - 9, 2010 Philadelphia, PA
The program will focus on clinical risk assessment and bridging the gap between preclinical data and clinical studies and offer strategies to better assess, predict and mitigate safety risks.

Safety Data Lifecycle Management

November 17 - 18, 2010 To Be Determined
Ensure Quality, Structure and Totality of Data Analysis throughout Development to Drive Risk Management Plans

 

FDA Risk Management / REMS Advisory Committee Meetings

Drug Safety and Risk Management Advisory Committee Meeting

September 14, 2010 University of Maryland
The committee will discuss the abuse potential of the drug dextromethorphan and the public health benefits and risks of dextromethorphan use as a cough suppressant in prescription and nonprescription drug products.

Previous page: In The News Next page: Press Releases
 
Register for periodic industry updates: